BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
DEL PRIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership1,586,384 shares
Latest Disclosed Value $ 89,614,833
Northern Trust Corp reports 2.48% increase in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 1,586,384 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $76,114,704 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,547,965 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 2.48% during the quarter. The current value of the position is $73,909,631 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,586,384 38,419 2.48 89,615 -2.59 0.0118
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,547,965 -114,303 -6.88 91,996 2.18 0.0117
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,662,268 7,157 0.43 90,028 -1.05 0.0115
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,655,111 -41,753 -2.46 90,981 -24.15 0.0125
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,696,864 -28,175 -1.63 119,951 5.79 0.0178
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,725,039 240,681 16.21 113,387 8.67 0.0161
2024-11-13 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,484,358 -93,901 -5.95 104,336 -19.70 0.0171
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,578,259 500,230 46.40 129,938 38.00 0.0219
2024-05-14 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,078,029 -72,754 -6.32 94,155 -15.14 0.0163
2024-02-13 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,150,783 -69,031 -5.66 110,958 2.81 0.0201
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,219,814 43,695 3.72 107,929 5.87 0.0209
2023-08-11 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,176,119 -129,319 -9.91 101,946 -19.69 0.0196
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,305,438 248 0.02 126,941 -6.02 0.0252
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,305,190 11,683 0.90 135,074 23.19 0.0283
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,293,507 -11,020 -0.84 109,650 1.43 0.0250
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,304,527 -21,927 -1.65 108,106 5.71 0.0232
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,326,454 -37,047 -2.72 102,269 -15.10 0.0180
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,363,501 8,188 0.60 120,465 15.00 0.0197
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,355,313 70,868 5.52 104,751 -2.26 0.0185
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,284,445 69,449 5.72 107,175 16.82 0.0189
2021-05-12 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,214,996 30,432 2.57 91,744 -11.68 0.0171
2021-02-11 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,184,564 -36,355 -2.98 103,876 11.83 0.0202
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,220,919 -73,890 -5.71 92,888 -41.84 0.0204
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,294,809 72,606 5.94 159,702 54.64 0.0378
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,222,203 83,344 7.32 103,275 7.25 0.0296
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,138,859 -53,379 -4.48 96,290 19.83 0.0216
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,192,238 -24,025 -1.98 80,358 -22.86 0.0192
2019-08-13 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,216,263 13,949 1.16 104,174 -2.46 0.0247
2019-05-13 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,202,314 20,108 1.70 106,801 6.10 0.0264
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,182,206 75,550 6.83 100,664 -6.20 0.0282
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,106,656 -2,407 -0.22 107,312 2.72 0.0263
2018-09-18 2018-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,109,063 12,326 1.12 104,475 17.50 0.0265
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,120,334 23,597 105,536
2018-05-09 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,096,737 -13,295 -1.20 88,912 -10.17 0.0231
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,110,032 5,952 0.54 98,981 -3.68 0.0251
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,104,080 6,509 0.59 102,758 3.09 0.0268
2017-08-11 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,097,571 31,113 2.92 99,682 6.48 0.0279
2017-05-12 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,066,458 26,940 2.59 93,614 8.71 0.0270
2017-02-13 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,039,518 -254,800 -19.69 86,114 -28.09 0.0264
2016-11-09 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,294,318 83,584 6.90 119,750 27.13 0.0373
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,210,734 44,857 3.85 94,196 -8.83 0.0306
2016-08-19 2016-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,165,877 31,645 2.79 103,319 -13.05 0.0343
2016-05-13 2016-03-31 13F Biomarin Pharmaceuti COMM 09061G101 1,165,868 96,161
2016-02-12 2015-12-31 13F Biomarin Pharmaceuti COMM 09061G101 1,134,232 -70,385 -5.84 118,822 -6.34 0.0394
2015-11-12 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,204,617 247,680 25.88 126,869 -3.07 0.0423
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 956,937 -376,456 -28.23 130,890 -21.23 0.0887
2015-08-13 2015-06-30 13F Biomarin Pharmaceuti COMM 009061G10 320,799 -1,012,594 43,879 0.0297
2015-05-14 2015-03-31 13F Biomarin Pharmaceuti COMM 09061G101 1,333,393 33,852 2.60 166,167 41.45 0.0500
2015-02-12 2014-12-31 13F Biomarin Pharmaceuti COM 09061G101 1,299,541 43,797 3.49 117,478 29.65 0.0355
2014-11-13 2014-09-30 13F Biomarin Pharmaceuti COMM 09061G101 1,255,744 235,662 23.10 90,614 42.79 0.0285
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL com 09061G101 1,020,082 -430,486 -29.68 63,459 -35.86 0.0198
2014-05-14 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,450,568 259,007 21.74 98,943 18.03 0.0311
2014-02-21 2013-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,191,561 71,015 6.34 83,826 3.66 0.0269
2014-02-12 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,191,561 83,826
2013-11-13 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,120,546 5,316 0.48 80,870 30.10 0.0285
2013-08-09 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,115,230 1,115,230 62,162 0.0225
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.